Tradestie Institutional Equity Comparison Engine
AAL vs CDT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AAL Overall Edge
AAL Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to American Airlines Group Inc. (AAL) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AAL trades at 10.9x Forward P/E with 1.8% operating margin (+19.3% YoY revenue) versus CDT at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, AAL sits in BREAKDOWN (22nd %ile IV; Dealer Gamma Walls on Pro) against CDT sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
AAL
AAL 10.9x vs CDT N/M Fwd P/E
Growth & Margin Winner
AAL
Op Margin 1.8% vs 0.0% ยท YoY +19.3% vs +0.0%
Momentum & Technical Winner
AAL
1Y -3.5% vs -86.8% ยท 52W Pos 21% vs 2%
Options & Structure Winner
AAL
BREAKDOWN (22nd %ile IV) vs BREAKDOWN (N/A IV)
AAL
NASDAQ
American Airlines Group Inc.
Air Transportation, Scheduled
$11.90
-6.45% 1D
Market Cap
$8.4B
1M Return
-5.56%
1Y Return
-3.49%
Forward P/E
10.9x
Unified AI Score
44.7 / 100
HOLD
Tech 25.0
Fund 45.0
Flow 58.0
Mom 60.0
CDT
NASDAQ
CDT Equity Inc. Common Stock
Pharmaceutical Preparations
$0.23
-13.89% 1D
Market Cap
$507,528
1M Return
+76.79%
1Y Return
-86.78%
Forward P/E
N/M
Unified AI Score
31.6 / 100
SELL
Tech 15.0
Fund 37.0
Flow 50.0
Mom 54.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
AAL -3.49%
CDT -86.78%
Spread: +83.29 pp (AAL Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
AAL TTM Op. Margin: 1.8%
CDT TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AAL vs CDT. Trailing 12-month operating profitability (AAL 1.8% vs CDT 0.0%) and valuation multiples (AAL 10.9x vs CDT N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AAL | CDT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $8.4B | $507,528 | Larger Scale | AAL |
| Trailing P/E Ratio Valuation | 11.2x | N/M | Lower Multiple | AAL |
| Forward P/E Ratio Valuation | 10.9x | N/M | Lower Multiple | AAL |
| Revenue Growth (YoY) Growth | +19.3% | +0.0% | Higher Growth | AAL |
| Operating Margin (TTM) Profitability | 1.8% | 0.0% | Higher Margin | AAL |
| Net Profit Margin Profitability | -0.8% | 0.0% | Higher Margin | CDT |
| Return on Equity (ROE) Capital Efficiency | 0.0% | -69.7% | Higher ROE | AAL |
| 52-Week Range Position Momentum | 21% ($10โ$19) | 2% ($0โ$11) | Stronger Trend | AAL |
| Beta / 30D Volatility Risk Regime | 1.82ฮฒ ยท 55% Vol | -17.75ฮฒ ยท 10175% Vol | Lower Realized Risk | AAL |
| Unified Institutional Score Composite Signal | 44.7 / 100 (HOLD) | 31.6 / 100 (SELL) | Higher Composite | AAL |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full AAL vs CDT Buy Guide
AAL
BREAKDOWN
105d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
22nd %ile
IV Regime
Compressed (<25th %ile)
CDT
BREAKDOWN
163d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither AAL nor CDT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.